Shin, Su Ryon
Harvard Medical School,
United States
2025 Rank: 23160
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 810 out of 156020 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 23160 | 25310 |
| Total Cites | 2627 | 2771 |
| H-index | 29 | 30 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 355 | 363 |
| Number of Single+First+Last Authored Papers | 62 | 62 |
| Total Cites to Single+First+Last Authored Papers | 774 | 812 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2002 | 2078 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.33 |
| Self-Citation Percentage |
5.20%
|
|
Shin, Su Ryon
Brigham and Women's Hospital,
United States
2024 Rank: 26768
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 860 out of 135958 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 26768 | 28082 |
| Total Cites | 2429 | 2572 |
| H-index | 27 | 28 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 317 | 325 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 644 | 676 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1834 | 1908 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.35 |
| Self-Citation Percentage |
5.56%
|
|
Shin, Su Ryon
Harvard Medical School,
United States
2023 Rank: 22600
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 676 out of 117692 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22600 | 23683 |
| Total Cites | 2667 | 2921 |
| H-index | 28 | 29 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 433 | 463 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 756 | 822 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1935 | 2036 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.43 |
| Self-Citation Percentage |
8.70%
|
|
Shin, Su Ryon
Harvard Medical School,
United States
2022 Rank: 32177
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 920 out of 103235 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32177 | 35120 |
| Total Cites | 2136 | 2315 |
| H-index | 26 | 27 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 415 | 429 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 565 | 595 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1513 | 1580 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.47 |
| Self-Citation Percentage |
7.73%
|
|
Shin, Su Ryon
Brigham and Women's Hospital,
United States
2021 Rank: 35951
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 932 out of 89177 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35951 | 38954 |
| Total Cites | 3168 | 3475 |
| H-index | 32 | 33 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 669 | 707 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 841 | 900 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2236 | 2381 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.46 |
| Self-Citation Percentage |
8.83%
|
|
Shin, Su Ryon
Harvard Medical School,
United States
2020 Rank: 38677
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Nanoscience & Nanotechnology
SubField 2:
Biomedical Engineering
Rank in SubField 1: 1057 out of 75210 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38677 | 38878 |
| Total Cites | 2140 | 2460 |
| H-index | 26 | 28 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 20 | 20 |
| Total Cites to Single+First Authored Papers | 488 | 549 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 551 | 622 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1540 | 1662 |
| Ratio of Total Citations to Distinct Citing Papers | 1.39 | 1.48 |
| Self-Citation Percentage |
13.01%
|
|
Related Profiles
Featured Profiles
Partner with Us
📢 Reach a targeted audience of science enthusiasts and professionals through our platform. Contact our marketing team:
business@topscinet.com cc: top2percentscientist@gmail.comGet a custom proposal tailored to your banner ad goals.
Partner with Us
📢 Partner with us and reach a targeted audience of science enthusiasts and professionals through our platform. Your company/institute’s banner could be here.